News and Media

UPM PHARMACEUTICALS®, INC. Announces Presentation at San Diego Biotechnology Discussion Group

Baltimore, MD, February 8 2011 – UPM is pleased to announce its recent sponsorship and presentation at SDBDG in San Diego California. As a sponsor for the event UPM is awarded an opportunity to present its drug development and cGMP manufacturing capabilities to the attending audience.
Frances Spaven, Ph.D., Vice President of Contract Services notes that "this was a tremendous opportunity for UPM, the attendance was excellent, the audience was absolutely appropriate for our valuable services, and further Sara Mathew our Manager of Business Development for the West Coast delivered a terrific presentation. The feedback she received was positive and gives us good reason to believe we will only expand our client foot print in this part of the US. We look forward to future opportunities to support the San Diego Biotech Discussion Group and its member companies."
Fully appreciating that time-to-market is critical, UPM offers remarkably flexible, affordable, and rapid outsourcing services designed to meet clients' specific development and manufacturing needs. Our clients represent both small and large companies within the pharmaceutical and biotechnology industries, as well as academic institutions who have a focus on clinical studies.
Contact:
Frank Sorce
973-765-0131 (office)
sorce@upm-inc.com
UPM Pharmaceuticals®, Inc.
6200 Seaforth Street, Baltimore, MD 21224
Phone: 410.843.3738
Fax: 410.633.4438

Formulation Evaluation
  • Content uniformity evaluation
  • Dissolution testing
  • Stability assessment
Regulatory Support
  • SUPAC application support
  • GMP/FDA/ICH guidance
  • Product development strategies
Analytical Services
  • HPLC based
  • Full ICH stability conditions
  • Dissolution testing
Clinical Manufacturing
  • cGMP manufacturing
  • Direct API fill into capsules
  • Dosage form preparation and blinding




All works © UPM Pharmaceuticals 2011
-